Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Phase I & IIA clinical trials

27 Feb 2013 - 28 Feb 2013 - London, UK



Bookmark and Share


The Phase I & IIa Clinical Trials conference has been revamped for 2013 to provide you with two highly focused and high quality streams, providing answers to the latest questions in early phase drug development. This year we will be looking at how we can design more effective and efficient Phase I & IIa clinical trials, benchmarking against current industry models to find out what works best and how we can adapt this to our trials going forward.

6 Reasons why you MUST attend this conference……

Over 160 attendees from small, medium and large pharma and biotech companies 

Wine Casino networking event - your opportunity to meet new faces in early phase clinical development 

8 interactive sessions: Don’t miss our regulatory Q&A to get the latest updates on EU and US regulations and find out how you can remain compliant 

70 speakers including 6 Vice Presidents, 10 Heads and 15 Directors from pharma and 10 CEOs and CMOs from biotech 

Increased focus on biotech  - with speakers from 13 leading biotech companies 

2 re-engineered streams including one stream entirely dedicated to outsourcing and patient recruitment in early phase trials 

Please quote CQ4170TN when booking your place.

For more information and to download the conference brochure, please visit: 

http://www.informa-ls.com/CQ4170TN




Further information
Scientific News
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
Cellular Origin of Skin Cancer Identified
Scientists have identified ‘cell of origin’ in the most common form of skin cancer, and followed the process that leads to tumour growth.
Enhancing Drug Safety with a Web-Based Data Tool
Online and open-access tool allows anyone to find, combine and analyse FDA drug information.
Genetic Missing Link Could Explain Mystery of Heritability
Mother’s diet during pregnancy can permanently affect offspring attributes through process that could be strongly influenced by genetic variation in an unexpected part of the genome.
Does the Transport of Next-Gen Vaccines Lie with E.coli?
Study shows harmless E.coli capsule could aid next-gen vaccine delivery and efficiency.
Breathing in a Cure
Researchers working on inhalable ibuprofen to treat cystic fibrosis.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!